SCHEMBL3479776

SCHEMBL3479776

CN1CCN(c2ccc3ccccc3c2F)c2ccc(-n3ncccc3=O)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.40
KCNH2 Q12809 1/20 0.37
SCN9A Q15858 1/20 0.35
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HTR3A P46098 2/20 0.32
HRH4 Q9H3N8 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
P2RX7 Q99572 1/20 0.31
F10 P00742 1/20 0.31
RAB9A P51151 3/20 0.31
NPC1 O15118 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ALDH1A1 P00352 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235782 0.86 HRH3 (0.39) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3479649 0.85 HRH3 (0.47) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3479568 0.84 HRH4 (0.40) SCN9ACYP1A1CYP1B1SLC6A2SLC6A4
SCHEMBL3479741 0.83 HRH3 (0.42) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3222466 0.82 HRH3 (0.39) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3479590 0.82 HRH3 (0.40) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3479734 0.81 HRH3 (0.39) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3479316 0.77 HRH3 (0.39) HRH3KCNH2SCN9ACA12CA1
SCHEMBL3231196 0.77 SLC6A2 (0.47) HRH3KCNH2SCN9ASLC6A2SLC6A4
SCHEMBL3225885 0.77 MAOA (0.39) SLC6A4HTR3AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HRH3 84/4885KCNH2 537/4885SCN9A 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.